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Abstract
Increased manganese (Mn) exposure is known to cause cognitive, psychiatric and motor deficits. 
Mn exposure occurs in different occupational settings, where the airborne Mn level and the size of 
respirable particulates may vary considerably. Recently the importance of the role of the cerebral 
cortex in Mn toxicity has been highlighted, especially in Mn-induced neuropsychological effects. 
In this study we used magnetic resonance imaging (MRI) to evaluate brain Mn accumulation using 
T1 signal intensity indices and to examine changes in brain iron content using T2* contrast, as 
well as magnetic resonance spectroscopy (MRS) to measure exposure-induced metabolite changes 
non-invasively in cortical and deep brain regions in Mn-exposed welders, Mn-exposed smelter 
workers and control factory workers with no measurable exposure to Mn. MRS data as well as T1 
signal intensity indices and T2* values were acquired from the frontal cortex, posterior cingulate 
cortex, hippocampus, and thalamus. Smelters were exposed to higher air Mn levels and had a 
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longer duration of exposure, which was reflected in higher Mn levels in erythrocytes and urine 
than in welders. Nonetheless, welders had more significant metabolic differences compared to 
controls than did the smelter workers, especially in the frontal cortex. T1 hyperintensities in the 
globus pallidus were observed in both Mn-exposed groups, but only welders showed significantly 
higher thalamic and hippocampal T1 hyperintensities, as well as significantly reduced T2* values 
in the frontal cortex. Our results indicate that (1) the cerebral cortex, in particular the frontal 
cortex, is clearly involved in Mn neurotoxic effects and (2) in spite of the lower air Mn levels and 
shorter duration of exposure, welders exhibit more extensive neuroimaging changes compared to 
controls than smelters, including measurable deposition of Mn in more brain areas. These results 
indicate that the type of exposure (particulate sizes, dust versus fume) and route of exposure play 
an important role in the extent of Mn-induced toxic effects on the brain.
Keywords
manganese neurotoxicity; magnetic resonance spectroscopy; magnetic resonance imaging; frontal 
cortex; welding; smelting
1. Introduction
As an essential trace element, manganese (Mn) is required for maintaining normal function 
in the human body. However, excessive exposure to Mn has been associated with Parkinson-
like symptoms including cognitive, psychiatric and motor deficits, as first described by 
Couper (1837) and currently known as manganism (Pal et al., 1999; Aschner and Aschner, 
2005; Josephs et al., 2005; Zheng et al., 2011). Moreover, occupational and environmental 
exposure to Mn is well documented to lead to significant neurotoxic effects, namely 
detrimental effects on neuropsychological functions, some of which persist or worsen after 
cessation of exposure (Mergler et al., 1994; Lucchini et al., 1999; Josephs et al., 2005; 
Josephs et al., 2005; Bowler et al., 2006; Greiffenstein and Lees-Haley, 2007; Menezes-
Filho et al., 2009; Bowler et al., 2011; Roels et al., 2012; Meyer-Baron et al., 2013; Zoni and 
Lucchini, 2013). The fact that cognitive changes are mostly associated with cortical brain 
regions, particularly the frontal cortex (Barbas, 2000; Chudasama and Robbins, 2006; Carter 
et al., 2009), emphasizes the importance of including cortical brain regions as targets for 
neuroimaging studies of Mn exposure.
Mn exposure is known to occur in different occupational settings, such as mining, steel and 
alloy production, welding, smelting, and dry-cell battery manufacturing, for which the types 
(i.e., fumes, inhalable dust) and levels of exposure can vary widely. Mn is a transition metal 
possessing multiple oxidation states capable of forming a series of oxides, among which 
Mn3O4 and MnO2 have been identified and measured in both welding and smelting aerosols 
(Jiang et al., 2007; Cowan et al., 2009; Keane et al., 2010). Nonetheless, the type of 
exposure in these two occupations is quite different.
Welding is a major occupational activity worldwide. In the US, more than 462,000 workers 
are involved in welding operations as full-time welders or as a part of their jobs (Bureau of 
Labor Statistics, 2009). Welding joins metals using different thermal procedures such as 
electric arc or gas flame welding. Concentrated fumes containing vaporized metals and 
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metal oxides are produced during the welding process. In these fumes, the diameter of 
individual particles can be less than 0.01 μm (Zimmer, 2002), and aggregation can result in 
particulates generally smaller than 1 μm in diameter (Sowards et al., 2010). More than 90% 
of the Mn-containing welding aerosol is composed of respirable particulates (particle size < 
10 μm) that can penetrate deeply into the lung. These Mn particulates may deposit in the 
alveoli and be converted to chemical forms of Mn (e.g. Mn2+) that are readily available for 
systemic absorption (Aschner et al., 2005). In an animal inhalation model, Mn from inhaled 
Mn-containing particulates has also been identified in the olfactory bulb, from whence it can 
be transported along the olfactory nerve further into the brain (Elder et al., 2006). However, 
the exact brain regions for Mn translocation and the resulting concentrations are still under 
debate (Dorman et al., 2002). More recently, Sen et al. used MR imaging to detect Mn in the 
olfactory bulb of asymptomatic welders (Sen et al., 2011).
Smelting, on the other hand, involves extraction of metals from their ores using heat and 
chemical agents. Aerosols generated during smelting processes contain both fumes and 
coarser dust particulates and are less well characterized than the welding fume aerosols. 
Penetration and deposition of the particulate matter in the respiratory tract is particle-size 
selective. Apart from respirable particulates, the aerosols from smelting operations may also 
contain a significant amount of biologically relevant non-respirable Mn particles (particle 
size 10 to 100 μm), which may enter into the gastrointestinal tract via the mucociliari 
escalator and lead to Mn absorption at a rate equivalent to that of oral Mn intake. For 
smelters, the non-respirable fraction is roughly 10% of the inhalable fraction of the aerosol 
(Ellingsen et al., 2003).
Magnetic resonance imaging (MRI) and spectroscopy (MRS) can be used to evaluate the 
accumulation of Mn in the brain and to determine Mn exposure-induced metabolite changes 
non-invasively. Paramagnetic Mn ions shorten proton relaxation times, yielding 
hyperintense signals in T1-weighted MR images of the brain. Signal intensity indices from 
T1-weighted images can be used as an indicator of Mn accumulation, which has been 
associated with gliosis and neurodegeneration (Newland, 1999; Pal et al., 1999). Increased 
signal intensity indices have been observed in the globus pallidus, caudate, putamen, and the 
olfactory bulb as a result of Mn exposure (Nelson et al., 1993; Kim et al., 1999; Josephs et 
al., 2005; Dorman et al., 2006A; Criswell et al., 2012). In addition, increased iron (Fe) 
concentration in the brain gives rise to local magnetic field inhomogeneities that increase 
proton spin dephasing and thus shorten the T2* relaxation time. The measurement of T2* 
values has therefore been used to evaluate tissue Fe concentration (Haacke et al., 2005). 
Brain Fe concentration is known to be elevated in the substantia nigra, globus pallidus and 
caudate of patients with Parkinson’s disease (Dexter et al., 1987; Griffiths and Grossman, 
1993; Batista-Nascimento et al., 2012; Rossi et al., 2014); however, it is much less studied 
in Mn-exposed workers. Several MRS studies have investigated Mn-induced neurochemical 
changes and some of the results seem to be inconsistent, such as decreased or no change of 
frontal N-acetyl aspartate (NAA) (Guilarte et al., 2006; Kim et al., 2007; Chang et al., 2009; 
Dydak et al., 2011; Long et al., 2014). In this study we present data on the effect of Mn 
exposure on metabolite levels, T1 signal hyperintensities and T2* values in two cortical and 
two deep brain regions for two different occupational settings with Mn exposure: welding 
and smelting.
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2. Materials and Methods
2.1. Subjects
14 male Mn-exposed welders (age (Median (Quantile 1, Quantile 3)), 30.5 (29.0, 37.3) 
years), 9 male Mn-exposed smelters (age 40.0 (33.0, 43.0) years) from two factories (a Mn-
Fe alloy factory and a construction machinery factory), and 23 age- and gender-matched 
controls who were manual workers with no history of Mn exposure (age 31.0 (26.5, 45.5) 
years), were recruited from Guangxi Province, China. All workers had no history of 
neurological or psychiatric disorders, and have worked a minimum of three years at their 
current job and work five 8-h days per week. Stationary air sampling was carried out 
similarly to that in a previous study (Jiang et al., 2007), using a Model BFC-35 pump 
equipped with a micro-porous filter (diameter of 40mm, pore size 0.8μm). Samples were 
collected for more than 10 working shifts at three locations within each work environment 
and then averaged to obtain a representative air Mn level for each group. No personal air 
sampling was performed. For the control group, airborne Mn values were below the limit of 
quantification of the flame atomic absorption spectrometric method (AAS) (Shimadzu 
Model AA-6800, Japan). Blood and urine samples were collected in the morning of the 
examination day (a weekend day) and processed using the same method as described 
previously (Jiang et al., 2007). Mn concentrations in erythrocytes and urine were determined 
using a model JY-70PII inductively coupled plasma-atomic emission spectrophotometer 
(ICP-AES, JY70P Type II, Jobin-Yvon Company, France). The detection limit for Mn using 
this method was 0.3 ng/ml.
The study protocol was reviewed and approved by the Human Subjects Institutional Review 
Board at both Purdue University, USA, and Guangxi Medical University, China. Written 
informed consent was obtained from each subject prior to participation in the study.
2.2. MR imaging and spectroscopy
MRI and MRS scans were performed on a 3T Philips Achieva whole-body clinical scanner 
(Philips Healthcare, Best, the Netherlands), equipped with an eight-channel head coil. Fast 
T2-weighted images were acquired for exact planning of the VOIs using a turbo spin-echo 
sequence (TR/TE=3000/80ms, flip angle=90°, bandwidth=204 Hz/pixel, 17 slices, slice 
thickness=4 mm, field of view=230×184 mm2, acquisition matrix: 400×320, 
resolution=0.5×0.5×4 mm3, SENSE factor 2). Short echo time 1H spectra (PRESS 
localization; TR/TE=1500/30ms; CHESS water suppression) were acquired in each subject 
from four volumes of interest (VOIs): frontal cortex (20×20×20 mm3), posterior cingulate 
cortex (PCC) (30×35×25mm3), right hippocampus (30×10×10 mm3), and a 30×30×25 mm3 
voxel centered on the right thalamus, but also containing portions of the globus pallidus, 
putamen, and other basal ganglia structures. To keep the overall scan time per subject on the 
order of 1 hour, the two off-center VOIs were only measured in the right brain hemisphere, 
assuming symmetric deposition and toxic effects of Mn as previously reported (Aschner and 
Aschner, 2005; Dorman et al. 2006A; Kim et al., 1999). The positioning of the VOIs is 
shown in Figure 1 and each VOI is centered at the Montreal Neurological Institute (MNI) 
coordinate [0, 46, 0], [0 −60, 24], [−26 −20 −21], [−19, −14, −3], respectively. For all of the 
VOIs, a reference spectrum was acquired without water suppression. These reference spectra 
Zaiyang et al. Page 4
Neurotoxicology. Author manuscript; available in PMC 2015 December 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
were then used for phase and frequency correction of the corresponding water-suppressed 
spectra, and additionally as a concentration reference for water-scaled metabolite ratios. 
Shimming and other preparation phases were performed fully automatically, resulting in line 
widths of < 15 Hz for the unsuppressed water peak for all spectra.
MRS data processing and quantification were performed with LCModel (Provencher, 1993), 
fitting each spectrum as a weighted linear combination of in vitro basis spectra from 
individual metabolite solutions. This basis set included NAA, myo-inositol (mI), creatine 
(Cr), glutamate (Glu), glutamine (Gln), glycerophosphocholine (GPC), phosphocholine 
(PCh), N-acetylaspartylglutamate (NAAG), and a number of minor metabolites. Three 
metabolite sums were examined as well: total choline (Cho) = GPC + Ph, total NAA = NAA 
+ NAAG, and Glx = Glu + Gln. LCModel also adds a series of macromolecule (MM) peaks 
in the fitting process, in particular MM20, the component centered at a chemical shift of 2.0 
ppm. All metabolite concentrations were scaled with respect to the unsuppressed water 
signal. However, because no corrections for relaxation were applied, concentrations are 
expressed here in institutional units. LCModel also reports an estimated relative standard 
deviation (%SD) for each metabolite and MM peak. Only fitting results with %SD values < 
20% were used for further statistical analysis.
High-resolution 3D T1-weighted fast-gradient echo images (TR/TE=9.7/4.6ms, flip 
angle=8°, bandwidth=142 Hz/pixel, 120 slices, slice thickness=1.25 mm, field of 
view=240×240×150 mm3, acquisition matrix: 240×240, resolution=1×1×1.25 mm3, SENSE 
factor 2) were used to calculate the regional signal intensity index, which was defined as the 
ratio of T1-weighted signal in a region of interest (ROI) within each of the four MRS VOIs 
to the same neck muscle reference ROI, sized 35 mm2 in area. The positions of the ROIs are 
centered at the MNI coordinate [0, 57, 8], [0 −44, 38], [24 −15 −12], [6, −14, 11], [0, −102, 
−103], respectively (Fig. 2). In addition, a fifth ROI for image analysis, centered at the MNI 
coordinate [16, 5, 2], was placed in the globus pallidus, which can show extensive Mn 
deposition and thus T1 hyperintensity. The positions of the ROIs for calculating T1 signal 
intensity indices are shown in Fig. 2. T2* maps using a fast field echo sequence (TR/
first_TE/delta_TE: 24.5/3.7/4.4, flip angle=20°, bandwidth=287 Hz/pixel, 80 slices, slice 
thickness: 1.5mm, field of view=240×180 mm2, acquisition matrix: 160×120, 
resolution=1.5×1.5×1.5 mm3, SENSE=2) were also acquired and used for estimating T2* 
values in the four ROIs. T2* values were calculated by fitting the signal intensity as a 
function of echo time using an exponential decay model.
2.3. Statistics
All analyses were carried out in R-2.15.1 (R Core Development System: http://www.r-
project.org). Due to the limited sample size and asymmetric data distributions, all analyses 
were performed using nonparametric methods. To assess whether any differences existed 
among the smelters, welders, and controls, we performed Kruskal-Wallis tests in place of 
the usual ANOVA models that are only appropriate for normally distributed data. Only 
when these tests indicated a significant difference were two-way comparisons among all 
three groups then performed using Wilcoxon rank-sum pairwise tests with the significance 
level set at alpha = 0.05. To control for multiple testing, we used a false discovery rate with 
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q-value ≤ 0.20 as a cutoff, i.e. only results with a q-value ≤ 0.20 are reported as significant. 
Using 0.20 as our cutoff, we acknowledge that on average 20% of the significant findings 
identified could potentially be false positives (Benjamini and Hochberg 1995).
3. Results
The smelter group had both significantly longer years of exposure and higher airborne Mn 
(as MnO2) levels than the welders, as shown in Table 1. Moreover, smelters had 
significantly higher erythrocyte Mn than welders and controls, as well as higher urine Mn 
than both welders and controls. Welders had higher erythrocyte Mn and urine Mn than 
controls. Age did not differ significantly among the three groups.
Table 2 summarizes the T1 signal intensity indices, T2* values, and metabolite levels in the 
different brain regions for the three groups. Metabolite levels are expressed as ratios to the 
unsuppressed water signal as reference, with appropriate correction factors applied in 
LCModel to yield approximate concentrations. As noted above, q-values were less than 0.2 
for all reported significant results. Figure 1 depicts the VOIs for the four brain regions 
chosen for metabolic evaluation and a representative spectrum for each region from a 
control subject. In the frontal cortex VOI, reduced Glu (p<0.01), reduced Cr (p<0.05) and 
increased MM20 (p<0.05) were measured in welders compared to controls, whereas 
smelters showed only reduced Glu compared to controls (p<0.05). In the thalamus VOI, 
decreased mI was found in both smelters and welders (both p<0.01) compared to controls. In 
the PCC VOI, Cho and mI were both reduced in welders (both p<0.05), while only mI was 
decreased in smelters (p<0.05) compared to controls. No significant differences were found 
in the hippocampus VOI.
Figure 3 contains representative T1-weighted axial brain images of a welder (A), a smelter 
(B) and a control subject (C), displaying an obvious hyperintensity of the globus pallidus in 
the Mn-exposed workers. Accordingly, the T1 signal intensity indices were significantly 
elevated in the globus pallidus for both welders (p<0.01) and smelters (p<0.05) compared to 
controls. However, in the other four VOIs, only welders showed significant changes: higher 
thalamic and hippocampal T1 signal intensity indices compared to controls (p<0.01 and 
p<0.0001, respectively). Welders also had a significantly higher hippocampal T1 signal 
intensity index than smelters (p<0.05). In addition, T2* values were significantly decreased 
in the frontal cortex of welders compared to controls (p<0.05), but not so for smelters. No 
significant changes in T2* were observed in the other VOI’s for either group.
4. Discussion
Welding and smelting are two different occupations that both involve exposure to airborne 
Mn. The results of this study show clearly that if the risk for neurotoxic effects in a 
particular occupational group is to be evaluated, assessment of air Mn levels and duration of 
exposure are not sufficient. The higher air Mn values and longer duration of exposure of the 
smelter group compared to the welder group are reflected in higher erythrocyte and urine 
Mn levels in the smelters. However, despite the higher level and duration of exposure, fewer 
changes in metabolism were observed in the smelters (decreased Glu in the frontal cortex, 
and reduced mI in the thalamus and PCC compared to controls) than in the welders, and 
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none of the brain regions investigated other than the globus pallidus area showed Mn 
accumulation in the smelters. In the welder group, we found significant changes of three 
metabolic moieties (Glu, Cr and MM20) in the frontal cortex, one (mI) in the thalamus, and 
two (Cho and mI) in the PCC compared to controls. In addition, welders also had higher 
thalamic and hippocampal T1 signal indices and tended to show a high frontal T1 signal 
index, indicating higher Mn accumulation in these regions. Moreover, welders showed 
significantly decreased T2* values in the frontal cortex, the likely result of higher Fe content 
in this region. These neuroimaging results suggest that even with lower exposure levels, the 
welders were affected more.
Kim et al. (1999) reported that 73.5% of welders while only 10.3% of smelters showed 
increased T1 signal intensities in the globus pallidus. These results are generally in line with 
our findings, although the authors did not provide the percentage increases in signal. While 
it is not clear what causes the more widespread effects in welders, it seems plausible that 
they are related to differences in the type of exposure between the two groups of Mn-
exposed workers. Welding aerosols have been well characterized in the literature, with a 
fraction of respirable particulates over 90%, and most of these being fine respirable 
particulates (<1μm) (Ellingsen et al., 2003). In contrast, not much is published about the 
aerosols that smelters are exposed to, except that they are a mixture of fumes (with small 
respirable particulates) and of dust (with larger respirable particulates as well as a small 
percentage of non-respirable particles). It is conceivable that the fine/ultrafine particles in 
the welding fumes penetrate and distribute more readily into the different brain areas 
(Dorman et al., 2002; Elder et al., 2006; Sen et al., 2011), especially via the olfactory route 
bypassing the blood-brain barrier, thereby causing the more widespread effects.
On the other hand, exposure to different metal mixtures should also be considered in both 
occupations. While the percentages of Fe and Mn are high in welding fumes, there are also 
other metals present such as aluminum (Al), copper and molybdenum (Li et al., 2004; 
Balkhyour and Goknil, 2010), depending on the components of the metal being welded, 
coatings, types of electrodes, etc. In our air sampling, the top 4 metals in welding fumes are 
Fe (45.5%), calcium (Ca, 34.3%), Al (6.7%), and Mn (5.6%), whereas those in smelting 
fumes are Ca (39.6%), Mn (25.5%), Fe (10.9%), and zinc (9.6%). In addition, even small 
amounts of other metals could potentially influence the overall neurotoxicity. Furthermore, 
welders may also be exposed to nonmetallic neurotoxic chemicals, such as carbon 
monoxide, phosgene and ozone, which may further influence the differences found in this 
study.
Due to the similarity of manganism to Parkinson’s disease and a high degree of Mn 
accumulation in the basal ganglia (Nagatomo et al., 1999; Aschner et al., 2005), many 
mechanistic studies of Mn neurotoxicity have focused on the basal ganglia in the past, 
especially prior to 2000 (Bhargava 1987; Eriksson et al., 1992; Cano et al., 1996; Pal et al., 
1999; Centonze et al., 2001; Fitsanakis et al., 2006). Yet the brain areas involved in these 
multiple reports of Mn-induced neuropsychological deficits, especially cognitive deficits, 
are to a large extent associated with cortical areas, in particular the frontal cortex (Barbas, 
2000; Chudasama and Robbins, 2006; Carter et al., 2009). Both the results from this study as 
well as other studies in the past show that Mn-induced metabolic changes also occur in brain 
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regions other than the thalamus and basal ganglia, which were traditionally thought to be the 
main target of Mn toxicity. Recently the cerebral cortex, especially the frontal cortex, has 
been shown to be a major target as well (Guilarte et al., 2008; Guilarte, 2013; Verina et al., 
2013). In animal studies, significantly increased amounts of Mn have been observed in the 
frontal cortex of rodents (Elder et al., 2006) and in non-human primates (Dorman et al., 
2006B; Bock et al., 2008) after Mn inhalation exposure. Reduced frontal NAA/Cr was 
shown to correlate with cumulative Mn exposure in Mn-exposed smelters (Dydak et al., 
2011). Decreased frontal mI/Cr was associated with verbal learning test scores and blood 
Mn levels in Mn-exposed welders (Chang et al., 2009). Moreover, decreased fractional 
anisotropy in frontal white matter was also reported in welders, indicating decreased frontal 
white matter microstructural integrity, which was also shown to be associated with subtle 
motor and cognitive deficits (Kim et al., 2011). Our decreased T2* values in the frontal 
cortex of welders indicate an increased concentration of Fe, which is known to be linked to 
increased oxidative stress, neuronal vulnerability and neurodegeneration (Zecca et al., 2004; 
Stankiewicz and Brass, 2009). Together these results point towards an intrinsic vulnerability 
of the frontal cortex to Mn-induced neurotoxicity, which is further supported by our 
observation that amongst the brain regions examined in this study, the largest number of 
metabolic changes among Mn-exposed workers was found in the frontal cortex. 
Furthermore, these metabolic and morphological changes in the frontal cortex corroborate 
the many recent results on cognitive deficits associated with occupational and environmental 
exposure to Mn.
Besides the frontal cortex, we also chose to study the thalamus, PCC and hippocampus. The 
hippocampus plays a vital role in memory, learning and spatial orientation, whereas the 
thalamus lies along cortico-thalamo-cortical pathways and is especially important for 
sensory and motor commands (Parkin, 1996; Akhondzadeh, 1999; Sherman, 2007). Both 
regions have been shown to have neurotoxic changes after Mn exposure (Finkelstein et al., 
2007; Burton and Guilarte, 2009; Dydak et al., 2011). The PCC is one of the most 
metabolically active brain regions, and it has been linked to cognitive control, working 
memory, associative learning and emotional salience (Pearson et al., 2011; Leech et al., 
2012). Metabolic changes in the frontal cortex, PCC and thalamus regions in this study may 
therefore be associated with Mn-induced neuropsychological and motor deficits.
In the last decade, several studies in humans and non-human primates investigated brain 
metabolite changes after exposure to Mn and showed diverging patterns of results. It needs 
to be pointed out that divergence in published MRS findings is not uncommon, unless 
standardized and rigorous MRS acquisition and analysis techniques are used, and described 
in the publications in sufficient detail for reproduction by an MRS expert (Bottomley, 1991). 
Kim et al. (2007) reported no significant changes in NAA/Cr, Cho/Cr and NAA/Cho ratios 
in the basal ganglia of welders and did not study other brain areas. Chang et al. (2009) 
investigated frontal grey matter and parietal white matter and only found decreased mI/Cr in 
the frontal cortex of welders. In our previous study of smelters, reduced NAA/Cr was only 
found in the frontal cortex, but not in the thalamus, putamen, or globus pallidus (Dydak et 
al., 2011). This frontal cortex finding was not reproduced in the current smelter population, 
possibly due to the small sample size or simply to the different type of exposure between the 
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two factory settings. Additionally, in our earlier study, a trend of reduced mI/Cr was 
observed but not reported in a larger thalamus-centered voxel (akin to the reduced thalamic 
mI levels found in the present study). In Mn-exposed monkeys, Guilarte et al. (2006) found 
decreased NAA/Cr in the parietal cortex and the frontal white matter but not in the striatum. 
Decreased NAA and Glu levels were reported in the hypothalamus of overnight food-
suppressed rats after Mn dosing (Just et al., 2011). The different results in these studies point 
out that a better understanding of the toxicodynamics of brain metabolites in Mn exposure 
requires consideration of the type and duration of exposure, the type and size of Mn 
particulates, the differences between humans and animal models, and characteristics of the 
subjects’ working conditions, e.g. whether they wear respiratory protection or not.
Decreases of Glu, Cr and Cho as shown in the present study have not been reported 
previously in Mn-exposed workers, but have been demonstrated in other studies on Mn 
neurotoxicity and related diseases. In an MRS study on Mn-treated cultured cells, Glu was 
found to decrease in neurons and neuron-astrocyte co-cultures, and decreases in mI were 
also observed in the co-cultures (Zwingmann et al., 2003). Glu plays an important role in the 
brain as the major excitatory neurotransmitter and a neuronal precursor for GABA 
(Erecinska et al., 1990). Lower frontal Glu has been associated with cognitive deficits (Ernst 
et al., 2010). Recently, decreased Cr in the putamen and the midbrain has been shown in 
idiopathic Parkinson’s disease patients (O’Neill et al., 2002; Hattingen et al., 2009). Cr is the 
key metabolite involved in energy metabolism. A lower Cr level was also associated with 
mitochondrial degeneration in lead neurotoxicity (Meng et al., 2003). mI/Cr and Cho/Cr 
ratios were reduced in patients with hepatic cirrhosis (Geissler et al., 1997; Spahr et al., 
2000) who have elevated Mn in the blood and in the brain due to damaged liver function 
(Butterworth et al., 1995; Choi et al., 2005). In the PCC of welders, the decrease of Cho, an 
important component of the cell membrane, may possibly indicate decreased cell membrane 
turnover or myelin alteration in this region. In the current study, the reduced mI is in general 
agreement with Chang et al. (2009), although they observed a decrease in frontal grey 
matter but not in parietal white matter (the two areas they examined), whereas we found a 
decrease in the thalamus and PCC but could not confirm lower mI in the frontal cortex. The 
reduced levels of mI (a glial marker) in the thalamus and PCC may indicate damage to glial 
cells in these regions. Reduced mI has also been associated with decreased verbal memory 
capability and altered mental status (Ross et al., 1994; Shawcross et al., 2004; Chang et al., 
2009). Thus in this context it may reflect the neurotoxic effects of Mn exposure.
While parallels to other studies and potential explanations for the metabolite changes found 
in this study are given above, the emphasis of our results are not the single findings of a 
particular metabolic concentration change, but rather the clear difference in number and 
locations of differences found in the welder population compared to controls, versus the 
smelter population compared to controls. Indeed, we note that the individual metabolic 
findings of the current study could be confounded by several limitations. First, the number 
of the smelters and welders that could be recruited was rather small, leading to a large q-
value in our multiple comparison statistics, i.e. 20% of the reported significant differences 
could be false positives. However, this caveat applies to all groups, and thus the difference 
between welders and smelters remains. Second, information about covariates, such as 
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education of the subjects or their possible Mn exposure outside of work, was unknown. 
Third, our stationary air sampling results represent average Mn levels for each group, which 
may underestimate the real exposure for each subject. Our results also indicate that 
measuring particle sizes in the air sampling is crucial for future studies that are to compare 
different occupational settings. Lastly, slight repositioning errors of the VOIs and ROIs may 
occur, although every effort has been made to ensure precise positioning among all subjects, 
such as using internal brain landmarks.
In spite of these limitations, our results allow for the conclusion that the frontal cortex shows 
a special vulnerability to Mn exposure, very much in line with early cognitive effects, and 
that more extensive Mn-induced neurotoxic changes can be found in welders than in 
smelters. Therefore the type of exposure and differences in occupational setting need to be 
considered when comparing different studies, and need to be carefully assessed in future 
studies evaluating the risk for neurotoxicity due to Mn exposure.
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• In vivo brain metabolism and Mn deposition were explored in Mn-exposed 
workers
• Two occupational settings were compared: smelting and welding
• The frontal cortex shows the most pronounced metabolic changes
• The results suggest that welders are more susceptible to Mn-induced 
neurotoxicity
Zaiyang et al. Page 15
Neurotoxicology. Author manuscript; available in PMC 2015 December 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1. 
Volumes of interest (VOIs) for four brain regions and representative short-TE spectra with 
LCModel fitting for each region: A, frontal cortex; B, posterior cingulate cortex (PCC); C, 
hippocampus; D, thalamus.
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Figure 2. 
Regions of interest (ROIs) for five brain regions: A, frontal cortex; B, posterior cingulate 
cortex (PCC); C, hippocampus; D, thalamus; E, globus pallidus; and F, a neck muscle 
reference region, for calculating T1 signal intensity indices and T2* values. Corresponding 
spectroscopy VOI’s for A–D are highlighted in yellow.
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Figure 3. 
Representative axial T1-weighted MRI brain images of a welder (A), a smelter worker (B), 
and a control worker (C), displaying the hyperintense signal associated with brain 
manganese deposition, especially in the globus pallidus, in both Mn-exposed groups.
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Table 1
Exposure information of Mn-exposed welders, smelters and controls (Median (Quartile 1, Quartile 3)).
Welders Smelters Controls
Airborne MnO2 [mg/m3] 0.03(0.02, 0.08)# 0.29(0.23, 0.39) N
Years of exposure 8.0(5.0, 12.0)## 18.0(14.0, 25.0) N/A
Erythrocyte Mn [mg/L] 0.9(0.8, 1.0)*# 1.3(1.2, 1.5)** 0.6(0.5, 0.7)
Urine Mn [μg/L] 20.0(15.0, 28.0)**# 37.5(29.6, 40.3)** 8.9(6.7, 10.8)
N: below the limit of quantification of the flame atomic absorption spectrometric method;
#
 p<0.05,
##
 p<0.01, for comparison between welders and smelters;
*p<0.05,
**p<0.01, for comparison between each Mn-exposed group and controls, respectively.
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Table 2
Metabolite levels (scaled to brain water content, reported in institutional units), T1 signal intensity indices and 
T2* values (Median (Quartile 1, Quartile 3)) in four brain regions for smelters and welders compared to 
controls. In addition, T1 signal intensity indices for the globus pallidus are also included. Group comparisons 
were performed using Kruskal-Wallis tests followed by Wilcoxon pairwise tests (significant changes are 
highlighted in bold font). A false discovery rate control was used to correct for multiple comparisons and the 
results with q≤0.20 are reported.
Frontal Cortex
Controls Welders Smelters
N-acetyl-aspartate(NAA) 6.8(6.5, 7.1) 6.4(6.1, 6.7) 6.6(6.4, 6.9)
NAA+N-acetylaspartylglutamate(NAAG) 7.2(6.8, 7.5) 7.0(6.7, 7.3) 6.9(6.8, 7.1)
myo-inositol(mI) 5.9(5.4, 6.4) 6.1(5.6, 6.4) 5.8(5.0, 6.3)
creatine(Cr) 6.3(6.0, 6.6) 5.9(5.7, 6.1)* 6.3(5.8, 6.6)
glutamate(Glu) 8.4(7.8, 8.8) 7.8(7.1, 8.1)** 7.6(7.5, 8.2)*
Glu+Gln(Glx) 12.2(9.8, 12.8) 9.8(9.2, 11.7) 11.5(10.1, 12.2)
total choline(Cho) 1.8(1.7, 1.9) 1.7(1.6, 1.9) 1.9(1.8, 2.0)
MM09 7.5(6.8, 8.7) 8.3(7.9, 9.0) 7.9(7.2, 8.3)
MM20 12.6(11.2, 14.5) 13.9(13.3, 16.1)* 13.3(11.8, 14.6)
T1 Signal Intensity Index 1.3(1.2, 1.4) 1.4(1.3, 1.5) 1.3(1.1, 1.4)
T2* (ms) 62.5(58.1,65.3) 57.4(55.5, 59.2)* 60.8(57.2, 66.0)
Thalamus
Controls Welders Smelters
N-acetyl-aspartate(NAA) 6.8(6.4, 7.0) 6.8(6.5, 7.0) 6.6(6.4, 6.9)
NAA+N-acetylaspartylglutamate(NAAG) 7.8(7.4, 8.1) 7.4(7.2, 7.5) 7.3(7.0, 7.8)
myo-inositol(mI) 4.5(4.1, 4.8) 3.9(3.6, 4.3)** 3.4(3.3, 3.9)**
creatine(Cr) 6.2(5.9, 6.4) 5.9(5.8, 6.2) 6.2(6.0, 6.4)
glutamate(Glu) 5.7(5.0, 6.5) 5.4(4.8, 6.0) 5.2(5.1, 5.5)
Glu+Gln(Glx) 8.3(7.2, 9.4) 7.2(6.4, 8.3) 7.3(7.2, 7.8)
total choline(Cho) 1.8(1.7, 2.0) 1.8(1.6, 1.9) 1.8(1.7, 2.0)
MM09 5.5(5.1, 6.1) 5.7(5.1, 6.0) 6.9(5.7, 6.2)
MM20 10.4(9.4, 10.9) 10.6(9.9, 11.8) 10.6(10.1, 11.6)
T1 Signal Intensity Index 1.4(1.1, 1.8) 1.8(1.7, 2.0)** 1.8(1.4, 2.0)
T2* (ms) 45.3(43.6, 49.7) 44.6(43.1, 49.4) 46.3(42.9, 50.8)
Posterior Cingulate Cortex
Controls Welders Smelters
N-acetyl-aspartate(NAA) 7.6(7.1, 8.0) 7.5(7.3, 8.0) 7.2(7.0, 7.8)
NAA+N-acetylaspartylglutamate(NAAG) 7.9(7.6, 8.1) 7.8(7.3, 8.0) 7.4(7.2, 7.8)
myo-inositol(mI) 5.2(5.1, 5.6) 4.9(4.6, 5.1)* 4.8(4.7, 5.1)*
creatine(Cr) 5.7(5.3, 6.1) 5.8(5.4, 6.0) 5.8(5.7, 6.2)
glutamate(Glu) 5.5(5.2, 6.0) 5.4(5.2, 6.0) 5.5(5.0, 5.7)
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Posterior Cingulate Cortex
Glu+Gln(Glx) 6.3(5.6, 7.1) 6.5(6.1, 6.8) 6.9(6.3, 7.3)
total choline(Cho) 1.1(1.0, 1.1) 1.0(0.9, 1.1)* 1.0(1.0, 1.0)
MM09 7.1(6.6, 8.4) 8.1(7.5, 8.7) 7.6(7.3, 8.4)
MM20 12.6(10.8, 13.6) 13.4(12.4, 14.2) 12.9(12.1, 13.8)
T1 Signal Intensity Index 1.6(1.4, 1.7) 1.5(1.4, 1.8) 1.2(1.1, 1.3)
T2* (ms) 54.5(48.3, 60.3) 56.0(53.4, 58.4) 56.8(55.6, 59.3)
Hippocampus
Controls Welders Smelters
N-acetyl-aspartate(NAA) 6.3(5.8, 6.7) 6.1(5.8, 6.4) 5.9(5.5, 6.4)
NAA+N-acetylaspartylglutamate(NAAG) 6.9(6.6, 7.3) 6.9(6.5, 7.3) 7.0(6.8, 7.5)
myo-inositol(mI) 6.7(6.4, 8.0) 6.4(5.8, 7.2) 6.9(6.0, 7.2)
creatine(Cr) 6.2(6.0, 6.6) 5.9(5.8, 6.4) 6.5(6.1, 6.6)
glutamate(Glu) 7.8(7.4, 9.0) 9.0(8.5, 9.8) 8.2(8.0, 9.0)
Glu+Gln(Glx) 11.3(9.9, 13.2) 13.3(10.5, 14.0) 12.8(9.0, 15.7)
total choline(Cho) 2.3(2.1, 2.4) 2.2(2.1, 2.3) 2.2(2.2, 2.4)
MM09 7.2(6.2, 7.6) 6.4(5.6, 7.1) 6.8(6.4, 7.5)
MM20 13.5(11.7, 14.2) 10.3(9.5, 13.0) 11.8(10.6, 14.8)
T1 Signal Intensity Index 1.8(1.6, 1.9) 2.1(1.9, 2.1)**,# 1.8(1.8, 1.9)
T2* (ms) 55.4(51.0, 60.6) 49.0(42.5, 54.9) 54.8(49.9, 56.3)
Globus Pallidus
Controls Welders Smelters
T1 Signal Intensity Index 2.7(2.5, 2.9) 3.8(3.5, 4.1)** 3.2(3.0, 3.3)*
*p<0.05,
**p<0.01, for comparison between each Mn-exposed group and controls;
#
 p<0.05, for comparison between welders and smelters.
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